(Q90029498)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30504359%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

title

Evidence-based management of immune thrombocytopenia: ASH guideline update (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30504359%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

1 reference

Cindy E Neunert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30504359%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

Nichola Cooper

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30504359%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

publication date

1 November 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30504359%20AND%20SRC:MED&resulttype=core&format=json

Hematology / the Education Program of the American Society of Hematology

10 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30504359%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

volume

2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30504359%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30504359%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

page(s)

568-575

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30504359%20AND%20SRC:MED&resulttype=core&format=json

Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura

10 April 2020

cites work

1 reference

12 December 2020

Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology

1 reference

12 December 2020

Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura

1 reference

12 December 2020

5- to 16-year follow-up following splenectomy in chronic immune thrombocytopenic purpura in children

1 reference

12 December 2020

The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura

1 reference

12 December 2020

Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications

1 reference

12 December 2020

Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura

1 reference

12 December 2020

Splenectomy for chronic idiopathic thrombocytopenic purpura in children: a single center study in China

1 reference

12 December 2020

Pediatric splenectomy for hematological diseases: outcome analysis

1 reference

12 December 2020

Splenectomy in children with chronic ITP: long-term efficacy and relation between its outcome and responses to previous treatments.

1 reference

12 December 2020

Splenectomy in children with idiopathic thrombocytopenic purpura: A prospective study of 134 children from the Intercontinental Childhood ITP Study Group

1 reference

12 December 2020

An 18-year review of open and laparoscopic splenectomy for idiopathic thrombocytopenic purpura

1 reference

12 December 2020

Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura

1 reference

12 December 2020

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

1 reference

12 December 2020

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

1 reference

12 December 2020

Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP.

1 reference

12 December 2020

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

1 reference

12 December 2020

Faster platelet recovery by high-dose dexamethasone compared with standard-dose prednisolone in adult immune thrombocytopenia: a prospective randomized trial.

1 reference

12 December 2020

Short-term and long-term failure of laparoscopic splenectomy in adult immune thrombocytopenic purpura patients: a systematic review

1 reference

12 December 2020

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

1 reference

12 December 2020

Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

1 reference

12 December 2020

Romiplostim or standard of care in patients with immune thrombocytopenia

1 reference

12 December 2020

Romiplostim in children with chronic refractory ITP: randomized placebo controlled study

1 reference

12 December 2020

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

1 reference

12 December 2020

A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia

1 reference

12 December 2020

An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP).

1 reference

12 December 2020

Total remission of severe immune thrombocytopenia after short term treatment with romiplostim

1 reference

12 December 2020

Prolonged remission from eltrombopag in chronic refractory idiopathic thrombocytopenic purpura

1 reference

12 December 2020

Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia

1 reference

12 December 2020

Single course of high dose dexamethasone is more effective than conventional prednisolone therapy in the treatment of primary newly diagnosed immune thrombocytopenia

1 reference

12 December 2020

Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists

1 reference

12 December 2020

Safety and efficacy of splenectomy in over 65-yrs-old patients with immune thrombocytopenia

1 reference

12 December 2020

Complete remission of refractory immune thrombocytopenia (ITP) with a short course of Romiplostim.

1 reference

12 December 2020

Update on romiplostim and eltrombopag indirect comparison

1 reference

12 December 2020

The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study

1 reference

12 December 2020

Laparoscopic splenectomy for primary immune thrombocytopenia: clinical outcome and prognostic factors

1 reference

12 December 2020

A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study).

1 reference

12 December 2020

Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients

1 reference

12 December 2020

Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Efficacy of standard dose rituximab for refractory idiopathic thrombocytopenic purpura in children.

1 reference

12 December 2020

Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial

1 reference

12 December 2020

High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial

1 reference

12 December 2020

Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study

1 reference

12 December 2020

Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study

1 reference

12 December 2020

Clinical Outcome and Predictive Factors in the Response to Splenectomy in Elderly Patients with Primary Immune Thrombocytopenia: A Multicenter Retrospective Study

1 reference

12 December 2020

Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study

1 reference

12 December 2020

A Randomized Trial of Daily Prednisone versus Pulsed Dexamethasone in Treatment-Naïve Adult Patients with Immune Thrombocytopenia: EIS 2002 Study

1 reference

12 December 2020

Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia

1 reference

12 December 2020

Long-term results of splenectomy in adult chronic immune thrombocytopenia

1 reference

12 December 2020

Efficacy and safety of thrombopoietin receptor agonists in patients with primary immune thrombocytopenia: A systematic review and meta-analysis

1 reference

12 December 2020

High dose Intravenous Anti-D Immune Globulin is More Effective and Safe in Indian Paediatric Patients of Immune Thrombocytopenic Purpura

1 reference

12 December 2020

10.1182/ASHEDUCATION-2018.1.568

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30504359%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30504359%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

1 reference